Oligoproline helices as structurally defined scaffolds for oligomeric G protein-coupled receptor ligands

被引：24

作者：

Bonger, Kimberly M. ^{[1
]}

Kapoerchan, Varsha V. ^{[1
]}

Grotenbreg, Gijsbert M. ^{[1
]}

van Koppen, Chris J. ^{[2
]}

Timmers, C. Marco ^{[3
]}

van der Marel, Gijsbert A. ^{[1
]}

Overkleeft, Herman S. ^{[1
]}

机构：

[1] Leiden Univ, Leiden Inst Chem, Gorlaeus Labs, Dept Bioorgan Synth, NL-2300 RA Leiden, Netherlands

[2] Schering Plough Res Inst, Dept Mol Pharmacol, NL-5340 BH Oss, Netherlands

[3] Schering Plough Res Inst, Dept Med Chem, NL-5340 BH Oss, Netherlands

来源：

ORGANIC & BIOMOLECULAR CHEMISTRY | 2010年 / 8卷 / 08期

关键词：

POLYPROLINE-II STRUCTURE; BIVALENT LIGANDS; CONFORMATION; STABILITY; AGONISTS; LENGTH;

D O I：

10.1039/b923556f

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Oligoprolines (OPs) are used as rigid backbone scaffolds for the design of oligomeric ligands that target specific G protein-coupled receptors. The OPs were designed to vary in length, the position and number of the ligand-functionalized residues incorporated. For all synthesized compounds a typical PP type II helix was evidenced by circular dichroism indicating that decoration of the helix with large ligands did not affect the helical conformation. Pharmacological evaluation revealed that oligomerization of an agonist with the use of an oligoproline scaffold showed an increase in potency when compared to the monomeric counterparts.

引用

页码：1881 / 1884

页数：4

共 31 条

[1] The lutropin/choriocrctnadotropin receptor, a 2002 perspective [J].

Ascoli, M ;

Fanelli, F ;

Segaloff, DL .

ENDOCRINE REVIEWS, 2002, 23 (02) :141-174

[2] Discovery of Selective Luteinizing Hormone Receptor Agonists Using the Bivalent Ligand Method [J].

Bonger, Kimberly M. ;

van den Berg, Richard J. B. H. N. ;

Knijnenburg, Annemiek D. ;

Heitman, Laura H. ;

van Koppen, Chris J. ;

Timmers, Cornelis M. ;

Overkleeft, Herman S. ;

van der Marel, Gijsbert A. .

CHEMMEDCHEM, 2009, 4 (07) :1189-1195

[3] STRUCTURE OF POLY-L-PROLINE [J].

COWAN, PM ;

MCGAVIN, S .

NATURE, 1955, 176 (4480) :501-503

[4] G protein-coupled receptor dimers: Functional consequences, disease states and drug targets [J].

Dalrymple, Matthew B. ;

Pfleger, Kevin D. G. ;

Eidne, Karin A. .

PHARMACOLOGY & THERAPEUTICS, 2008, 118 (03) :359-371

[5] Collagen stability: Insights from NMR spectroscopic and hybrid density functional computational investigations of the effect of electronegative substituents on prolyl ring conformations [J].

DeRider, ML ;

Wilkens, SJ ;

Waddell, MJ ;

Bretscher, LE ;

Weinhold, F ;

Raines, RT ;

Markley, JL .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (11) :2497-2505

[6] Probing length effects and mechanism of cell penetrating agents mounted on a polyproline helix scaffold [J].

Geisler, Iris ;

Chmielewski, Jean .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (10) :2765-2768

[7] G-protein-coupled receptor oligomerization and its potential for drug discovery [J].

George, SR ;

O'Dowd, BF ;

Lee, SR .

NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (10) :808-820

[8] Short, highly efficient syntheses of protected 3-azido- and 4-azidoproline and their precursors [J].

Gómez-Vidal, JA ;

Silverman, RB .

ORGANIC LETTERS, 2001, 3 (16) :2481-2484

[9] G-protein coupled receptors bivalent ligands and drug design [J].

Halazy, S .

EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (04) :431-446

[10] [3H]Org 43553, the first low-molecular-weight agonistic and allosteric Radioligand for the human luteinizing hormone receptor [J].

Heitman, Laura H. ;

Oosterom, Julia ;

Bonger, Kimberly M. ;

Timmers, Cornelis M. ;

Wiegerinck, Peter H. G. ;

IJzerman, Adriaan P. .

MOLECULAR PHARMACOLOGY, 2008, 73 (02) :518-524

← 1 2 3 4 →